In the current study, CD30 was expressed in 47.3% of cases, which is much higher than the rate reported in another study of mature T-cell and NK-cell lymphomas (with the exception of ALCL) [17]. The gene discussed is TNFRSF8; the disease is anaplastic large cell lymphoma.